Trust Company of Vermont’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-27
| Closed | -$4K | – | 539 |
|
|
2021
Q2 | $4K | Sell |
27
-66
| -71% | -$9.78K | ﹤0.01% | 708 |
|
|
2021
Q1 | $15K | Hold |
93
| – | – | ﹤0.01% | 588 |
|
|
2020
Q4 | $22K | Hold |
93
| – | – | ﹤0.01% | 531 |
|
|
2020
Q3 | $20K | Sell |
93
-40
| -30% | -$8.6K | ﹤0.01% | 527 |
|
|
2020
Q2 | $38K | Hold |
133
| – | – | ﹤0.01% | 465 |
|
|
2020
Q1 | $38K | Buy |
133
+26
| +24% | +$7.43K | ﹤0.01% | 471 |
|
|
2019
Q4 | $31K | Hold |
107
| – | – | ﹤0.01% | 534 |
|
|
2019
Q3 | $16K | Hold |
107
| – | – | ﹤0.01% | 670 |
|
|
2019
Q2 | $10K | Buy |
107
+34
| +47% | +$3.18K | ﹤0.01% | 749 |
|
|
2019
Q1 | $7K | Buy |
73
+33
| +83% | +$3.16K | ﹤0.01% | 759 |
|
|
2018
Q4 | $6K | Buy |
+40
| New | +$6K | ﹤0.01% | 810 |
|